(917) 310-3371
Insurance
Use the insurance page when prior authorization, exclusions, savings rules, or plan design are the real question.
Nao Medical offers provider-guided Zepbound evaluation across NYC and Long Island, including coverage review, self-pay workflow planning, pharmacy-availability troubleshooting, and branded comparison against Wegovy when the patient is already searching by medication name.
Zepbound is reviewed for adults with obesity, or adults with overweight plus at least one weight-related medical condition, alongside a reduced-calorie diet and increased physical activity. FDA also approved Zepbound for some adults with moderate to severe obstructive sleep apnea and obesity. The actual decision still depends on medical history, GI tolerance, current medications, thyroid-cancer risk factors, pregnancy planning, and whether another GLP-1 path fits better.
Many major insurance plans are accepted for eligible medical weight-loss visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Zepbound prescription coverage is separate from visit coverage and often depends on obesity-drug exclusions, prior authorization rules, employer carve-outs, and the pharmacy benefit.
Nao Medical offers provider-guided Zepbound evaluation across NYC and Long Island, including coverage review, self-pay workflow planning, pharmacy-availability troubleshooting, and branded comparison against Wegovy when the patient is already searching by medication name.
Patients searching the brand name usually need a different answer than patients searching a generic GLP-1 term. The page should separate branded access questions from generic weight-loss education.
The visit, the prescription, the prior-authorization path, the self-pay fallback, and the refill plan are different decisions. A good program explains each one clearly.
Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or other GLP-1 agonists. Personal or family history of medullary thyroid carcinoma or MEN2, pancreatitis questions, gallbladder symptoms, kidney issues, planned surgery, pregnancy planning, and severe GI symptoms all need review first.
Zepbound and Wegovy are both once-weekly branded obesity medications, but Zepbound uses tirzepatide (GIP plus GLP-1) while Wegovy uses semaglutide (GLP-1 only). Lilly's SURMOUNT-5 results showed higher average weight loss with Zepbound than Wegovy at 72 weeks, but the better fit still depends on coverage, tolerability, refill stability, and whether the patient is already doing well on Wegovy.
Use the insurance page when prior authorization, exclusions, savings rules, or plan design are the real question.
Use the self-pay page when the patient wants to move without waiting on coverage and needs the operational steps mapped out clearly.
Use the availability page when the real friction is dose fulfillment, refill timing, or channel stability.
Use the comparison page when the patient already knows the decision is between the two leading branded obesity medications.
These existing weight-loss clinic pages are the practical next step when patients want an in-person path for GLP-1 evaluation, coverage review, refill support, and long-term follow-up close to home.
Bronx
932 E 174th St, Bronx, NY 10460
A Bronx access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods.
View weight-loss location Get directions
Queens
37-15 23rd Ave, Astoria, NY 11105
A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods.
View weight-loss location Get directions
Bronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods.
View weight-loss location Get directions
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
A Brooklyn access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods.
View weight-loss location Get directions
Long Island
232 W Old Country Rd, Hicksville, NY 11801
A Long Island access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities.
View weight-loss location Get directions
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods.
View weight-loss location Get directions
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods.
View weight-loss location Get directions
Queens
30-07 36th Ave, Astoria, NY 11106
A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods.
View weight-loss location Get directions
Long Island
135 Mineola Blvd, Mineola, NY 11501
A Long Island access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities.
View weight-loss location Get directions
Manhattan
259 1st Ave, New York, NY 10003
A Manhattan access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods.
View weight-loss location Get directions
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
A Brooklyn access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods.
View weight-loss location Get directionsMany major insurance plans are accepted for eligible medical weight-loss visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Zepbound prescription coverage is separate from visit coverage and often depends on obesity-drug exclusions, prior authorization rules, employer carve-outs, and the pharmacy benefit.
Zepbound self-pay is usually a workflow, not just a price. It starts with the visit, medical review, and prescription, then moves into dose selection, pharmacy channel, program eligibility, refill timing, and follow-up. Some self-pay programs depend on staying inside refill windows, so operational planning matters.
The FDA resolved the national tirzepatide shortage in October 2024, but patients can still run into localized supply disruptions as product moves through wholesalers, pharmacies, and dose-specific refill queues. Prior authorization timing, refill gaps, and whether the prescription is filled through a retail or direct channel can all change whether the medication is actually available when the patient needs it.
Use the current weight-loss hub when the patient still needs the broad parent page for booking flow, locations, and overall program context.
Use the tirzepatide page when the patient wants the broader molecule page rather than the brand-first access lane.
Use the Wegovy lane when the patient is leaning toward semaglutide instead of tirzepatide.
Use the Wegovy follow-up page when the patient already started semaglutide and the real need is ongoing titration and refill support.
What patients say about Nao Medical
Verified Patient
This answered the Zepbound-specific questions I actually had before booking.
Verified Patient
Helpful that insurance, self-pay, and availability were separated instead of being mashed into one generic page.
Verified Patient
The location section made it easier to move from research into a real visit.
Verified Patient
This felt much more practical than most NYC Zepbound pages because it covered refill and pharmacy issues too.
Verified Patient
The comparison section made it clearer when Zepbound fits better than Wegovy and when it does not.
Use insurance for prior-authorization questions, self-pay workflow when coverage is the blocker, availability when fulfillment is unstable, and the comparison page when the real decision is Zepbound versus Wegovy.
Open Zepbound insurance page